NO20012090L - Anvendelse av thiazolidindioner alene eller sammen med andre midler for å blokkere oxytocin medierte virkninger så somuterinsammentrekninger ved prematur födsel eller laktasjon - Google Patents
Anvendelse av thiazolidindioner alene eller sammen med andre midler for å blokkere oxytocin medierte virkninger så somuterinsammentrekninger ved prematur födsel eller laktasjonInfo
- Publication number
- NO20012090L NO20012090L NO20012090A NO20012090A NO20012090L NO 20012090 L NO20012090 L NO 20012090L NO 20012090 A NO20012090 A NO 20012090A NO 20012090 A NO20012090 A NO 20012090A NO 20012090 L NO20012090 L NO 20012090L
- Authority
- NO
- Norway
- Prior art keywords
- alone
- thiazolidinediones
- lactation
- agents
- block
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Det er beskrevet fremgangsmåter for å forhindre eller redusere oksytosin- mediert virkning ved anvendelse av et tiazolidindion, så som troglitazon, eller tiazolidindion-lignende forbindelser. Disse metodene beskriver anvendelse av disse forbindelsene alene eller i kombinasjon med minst et annet middel, så som et tokolytisk middel. Dette tilveiebringer et nytt terapeutisk regime for behandling av oksytosin-medierte virkninger, for eksempel induksjon av uterinsammentrekningér, prostaglandin frigjøring og melkeutsondring. Betingelser så som premature veer og veer før fødsel ved keisersnitt kan følgelig bli behandlet ifølge disse metodene.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10613398P | 1998-10-29 | 1998-10-29 | |
PCT/US1999/025433 WO2000025781A1 (en) | 1998-10-29 | 1999-10-29 | Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20012090D0 NO20012090D0 (no) | 2001-04-27 |
NO20012090L true NO20012090L (no) | 2001-06-27 |
Family
ID=22309672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20012090A NO20012090L (no) | 1998-10-29 | 2001-04-27 | Anvendelse av thiazolidindioner alene eller sammen med andre midler for å blokkere oxytocin medierte virkninger så somuterinsammentrekninger ved prematur födsel eller laktasjon |
Country Status (19)
Country | Link |
---|---|
US (1) | US7528133B1 (no) |
EP (1) | EP1126844A1 (no) |
JP (1) | JP2002528500A (no) |
KR (1) | KR20010089381A (no) |
CN (1) | CN1328456A (no) |
AU (1) | AU1330800A (no) |
BR (1) | BR9915820A (no) |
CA (1) | CA2348910A1 (no) |
CZ (1) | CZ20011524A3 (no) |
HK (1) | HK1041213A1 (no) |
HU (1) | HUP0104900A3 (no) |
ID (1) | ID29352A (no) |
IL (1) | IL142841A0 (no) |
MX (1) | MXPA01004257A (no) |
NO (1) | NO20012090L (no) |
PL (1) | PL347508A1 (no) |
TR (1) | TR200101882T2 (no) |
WO (1) | WO2000025781A1 (no) |
ZA (1) | ZA200103999B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004062563A2 (en) * | 2003-01-16 | 2004-07-29 | Université de Lausanne | Methods for screening for therapeutic agents that are useful in the treatment of oxytocin and vasopressin-related disorders |
US20150004144A1 (en) | 2011-12-02 | 2015-01-01 | The General Hospital Corporation | Differentiation into brown adipocytes |
EP2912458B1 (en) | 2012-10-24 | 2018-07-18 | NYU Winthrop Hospital | Non-invasive biomarker to identify subjects at risk of preterm delivery |
US10555934B2 (en) * | 2016-01-04 | 2020-02-11 | ObsEva S.A. | Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof |
SG11202002065VA (en) | 2017-09-13 | 2020-04-29 | Progenity Inc | Preeclampsia biomarkers and related systems and methods |
EP4070113A4 (en) | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5478852C1 (en) * | 1993-09-15 | 2001-03-13 | Sankyo Co | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus |
US5370135A (en) * | 1993-10-13 | 1994-12-06 | Biex, Inc. | Use of estriol measurement to monitor tocolytic therapy |
TWI238064B (en) | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
EP0783888A1 (en) * | 1995-12-26 | 1997-07-16 | Sankyo Company Limited | Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis |
EP0844997A1 (en) * | 1996-06-19 | 1998-06-03 | Dr. Reddy's Research Foundation | Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation |
US5814647A (en) * | 1997-03-04 | 1998-09-29 | Board Of Regents, The University Of Texas System | Use of troglitazone and related compounds for the treatment of the climacteric symptoms |
-
1999
- 1999-10-29 ID IDW00200101157A patent/ID29352A/id unknown
- 1999-10-29 CA CA002348910A patent/CA2348910A1/en not_active Abandoned
- 1999-10-29 CZ CZ20011524A patent/CZ20011524A3/cs unknown
- 1999-10-29 KR KR1020017005411A patent/KR20010089381A/ko not_active Application Discontinuation
- 1999-10-29 TR TR2001/01882T patent/TR200101882T2/xx unknown
- 1999-10-29 HU HU0104900A patent/HUP0104900A3/hu unknown
- 1999-10-29 IL IL14284199A patent/IL142841A0/xx unknown
- 1999-10-29 JP JP2000579222A patent/JP2002528500A/ja not_active Withdrawn
- 1999-10-29 AU AU13308/00A patent/AU1330800A/en not_active Abandoned
- 1999-10-29 EP EP99956774A patent/EP1126844A1/en not_active Withdrawn
- 1999-10-29 CN CN99813856A patent/CN1328456A/zh active Pending
- 1999-10-29 WO PCT/US1999/025433 patent/WO2000025781A1/en not_active Application Discontinuation
- 1999-10-29 BR BR9915820-5A patent/BR9915820A/pt not_active IP Right Cessation
- 1999-10-29 MX MXPA01004257A patent/MXPA01004257A/es unknown
- 1999-10-29 PL PL99347508A patent/PL347508A1/xx not_active Application Discontinuation
- 1999-10-29 US US10/069,744 patent/US7528133B1/en not_active Expired - Fee Related
-
2001
- 2001-04-27 NO NO20012090A patent/NO20012090L/no not_active Application Discontinuation
- 2001-05-16 ZA ZA200103999A patent/ZA200103999B/en unknown
-
2002
- 2002-04-15 HK HK02102806.8A patent/HK1041213A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1126844A1 (en) | 2001-08-29 |
CA2348910A1 (en) | 2000-05-11 |
JP2002528500A (ja) | 2002-09-03 |
ZA200103999B (en) | 2002-08-16 |
ID29352A (id) | 2001-08-23 |
MXPA01004257A (es) | 2002-06-21 |
HUP0104900A2 (hu) | 2002-04-29 |
PL347508A1 (en) | 2002-04-08 |
US7528133B1 (en) | 2009-05-05 |
CN1328456A (zh) | 2001-12-26 |
WO2000025781A1 (en) | 2000-05-11 |
IL142841A0 (en) | 2002-03-10 |
AU1330800A (en) | 2000-05-22 |
BR9915820A (pt) | 2001-10-30 |
KR20010089381A (ko) | 2001-10-06 |
CZ20011524A3 (cs) | 2002-01-16 |
HUP0104900A3 (en) | 2003-02-28 |
HK1041213A1 (zh) | 2002-07-05 |
NO20012090D0 (no) | 2001-04-27 |
TR200101882T2 (tr) | 2001-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Buchanan et al. | Return of spermatogenesis after stopping cyclophosphamide therapy | |
ATE328612T1 (de) | Therapeutische zusammensetzungen zur behandlung von schleimhypersekretion | |
Van der Hulst et al. | Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication | |
NO20012090L (no) | Anvendelse av thiazolidindioner alene eller sammen med andre midler for å blokkere oxytocin medierte virkninger så somuterinsammentrekninger ved prematur födsel eller laktasjon | |
WO2004067057A3 (en) | Catheter with disruptable guidewire channel | |
DK0799037T3 (da) | Præparat til behandling af allergisk rhinitis og andre lidelser, herunder descarboetoxyloratadin | |
RU93052390A (ru) | Способ лечения шизофрении, применение комбинации арахидоновой и докозагексановой кислот для получения лекарственного средства для лечения шизофрении | |
WO2006023056A3 (en) | System and method for treating cardiac arrest and myocardial infarction | |
WO2000064456A3 (en) | Substitution infusion fluid and citrate anticoagulation | |
WO2007047722A3 (en) | Methods for treating disorders associated with hyperlipidemia in a mammal | |
Miwa et al. | Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis | |
NO20071704L (no) | Prostaglandinderivater for behandling av gastrointestinal forstyrrelse | |
CN208047649U (zh) | 一种适宜规模化养羊的保定装置 | |
CN214343208U (zh) | 一种骨盆骨伤紧急处理装置 | |
WO2006014162A3 (en) | Methods of using regenerative cells in the treatment of renal diseases and disorders | |
Prasad et al. | A comparative analysis of the efficacy of topical phenytoin with conventional wound dressing in healing of diabetic foot ulcers | |
Riedl et al. | A Prospective Randomized Placebo-Controlled Multicenter Study on the Efficacy of Intravesical Hyaluronan in Bladder Pain Syndrome/Interstitial Cystitis and Considerations for Designing Future Trials | |
Soleimani et al. | The effectiveness of sublingual misoprostol in prevention of bleeding during cesarean delivery | |
CN206257213U (zh) | 一种钢丝绳加长装置 | |
AU626390B2 (en) | Method for silicon reduction with dimercaptosuccinic acid (dmsa) | |
JPS5256076A (en) | Process of adsorption or tion exchange of moving bed type and its equi pment | |
WO2023042209A3 (en) | Treatment of myeloid malignancies | |
Butler | Treatment of Refractory Donor Site Seromas with Percutaneous Instillation of Tisseel Fibrin Sealant | |
CN204636541U (zh) | 一种结核病人痰样处理器 | |
JPS5431098A (en) | Regenerating method for activated alumina particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |